Development and Validation of a Three-Parameter Scoring System for Monitoring HIV/AIDS Patients in Low-Resource Settings Using Hematological Parameters

References

• UNAIDS. AIDS statistics—fact sheet. Unaids org; 2021.
   Google Scholar
• Barbaro G, Scozzafava A, Mastrolorenzo A, Supuran CT. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des. 2005;11(14):1805–1843. doi:10.2174/1381612053764869
   PubMed Web of Science ®Google Scholar
• Nosyk B, Min JE, Lima VD, Hogg RS, Montaner JS. Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study. Lancet HIV. 2015;2(9):e393–e400. doi:10.1016/S2352-3018(15)00127-7
   PubMed Web of Science ®Google Scholar
• HIV/AIDS JUNPo. Fast-track: ending the AIDS epidemic by 2030. Geneva: UNAIDS; 2014.
   Google Scholar
• UNAIDS. Report on the global AIDS epidemics 2012; 2012.
   Google Scholar
• Parker R. The global HIV/AIDS pandemic, structural inequalities, and the politics of international health. Am J Public Health. 2002;92(3):343–347. doi:10.2105/AJPH.92.3.343
   PubMed Web of Science ®Google Scholar
• Mwau M, Syeunda CA, Adhiambo M, et al. Scale-up of Kenya’s national HIV viral load program: findings and lessons learned. PLoS One. 2018;13(1):e0190659. doi:10.1371/journal.pone.0190659
   PubMed Web of Science ®Google Scholar
• Lecher S, Williams J, Fonjungo PN, et al. Progress with scale-up of HIV viral load monitoring—seven sub-Saharan African countries, January 2015–June 2016. Morb Mortal Wkly Rep. 2016;65(47):1332–1335. doi:10.15585/mmwr.mm6547a2
   PubMed Web of Science ®Google Scholar
• Gilks C, Vitoria M. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach; 2006.
   Google Scholar
• World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach-2010 Revision. World Health Organization; 2010.
   Google Scholar
• Belaunzarán-Zamudio PF, Caro-Vega YN, Shepherd BE, et al. Monitoring of HIV treatment in seven countries in the WHO region of the Americas. Bull World Health Organ. 2015;93:529–539. doi:10.2471/BLT.14.147447
   PubMed Web of Science ®Google Scholar
• Ford N, Meintjes G, Pozniak A, et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis. 2015;15(2):241–247. doi:10.1016/S1473-3099(14)70896-5
   PubMed Web of Science ®Google Scholar
• Kwantwi LB, Tunu BK, Boateng D, Quansah DY. Body mass index, haemoglobin, and total lymphocyte count as a surrogate for CD4 count in resource limited settings. J Biomark. 2017;2017:1–6. doi:10.1155/2017/7907352
   Google Scholar
• Acheampong I, Quaye L, Obirikorang C. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings; 2012.
   Google Scholar
• Rostina R, Aprianti S, Arif M. Prediksi jumlah sel limfosit T Cd4+ menggunakan nilai TLC (total lymphocyte count) pada penderita HIV/Aids. Indones J Clinical Pathol Med Lab. 2008;14(2):64–65. doi:10.24293/ijcpml.v14i2.902
   Google Scholar
• Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. JAIDS. 2005;39(5):620–625.
   Google Scholar
• Zhang Q, Rojhani A, Gulló-Rivera A, Kwak S. Prevalence and knowledge of anemia among pregnant women enrolled in women, infants and children supplemental food program. Nutr Food Sci. 2018;48(6):990–1002. doi:10.1108/NFS-03-2018-0097
   Web of Science ®Google Scholar
• Spacek LA, Griswold M, Quinn TC, Moore RD. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS. 2003;17(9):1311–1317. doi:10.1097/00002030-200306130-00005
   PubMed Web of Science ®Google Scholar
• Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008;3(6):e2516. doi:10.1371/journal.pone.0002516
   PubMed Web of Science ®Google Scholar
• Mathews SE, Srivastava D, Yadav RB, Sharma A. Association of hematological profile of human immunodeficiency virus-positive patients with clinicoimmunologic stages of the disease. J Lab Physicians. 2013;5(01):34–37. doi:10.4103/0974-2727.115929
   PubMedGoogle Scholar
• Daka D, Loha E. Relationship between Total Lymphocyte Count (TLC) and CD4 count among peoples living with HIV, Southern Ethiopia: a retrospective evaluation. AIDS Res Ther. 2008;5:1–5. doi:10.1186/1742-6405-5-26
   PubMedGoogle Scholar
• Akanmu A, Akinsete I, Eshofonie A, Davies A, Okany C. Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral. Niger Postgrad Med J. 2001;8(3):105. doi:10.4103/1117-1936.170869
   PubMedGoogle Scholar
• Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–954. doi:10.7326/0003-4819-126-12-199706150-00003
   PubMed Web of Science ®Google Scholar
• Yoshimura K. Current status of HIV/AIDS in the ART era. J Infect Chemother. 2017;23(1):12–16. doi:10.1016/j.jiac.2016.10.002
   PubMed Web of Science ®Google Scholar
• Abgrall S, Del Amo J. Effect of sociodemographic factors on survival of people living with HIV. Curr Opin HIV AIDS. 2016;11(5):501–506. doi:10.1097/COH.0000000000000301
   PubMed Web of Science ®Google Scholar
• Munyazesa E, Emile I, Mutimura E, et al. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study. BMJ open. 2012;2(6):e001600. doi:10.1136/bmjopen-2012-001600
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Mahajan AP, Hogan JW, Snyder B, et al. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. JAIDS. 2004;36(1):567–575. doi:10.1097/00126334-200405010-00004
   Google Scholar
• Mbanya D, Assah F, Ndembi N, Kaptue L. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? Int J Infect Dis. 2007;11(2):157–160. doi:10.1016/j.ijid.2006.02.008
   PubMed Web of Science ®Google Scholar
• Muhamad RF, Solichul H, Hadi S. The correlation between total lymphocyte count, hemoglobin levels, lymphocyte/leukocyte ratio (LLR), and lymphocyte/neutrophil ratio (LNR) to CD4 levels in patients with human immunodeficiency virus infection at sanglah hospital. Bali Med J. 2019;8(2):429–433. doi:10.15562/bmj.v8i2.1408
   Web of Science ®Google Scholar
• Miguez-Burbano M, Burbano X, Rodriguez A, Lecusay R, Rodriguez N, Shor-Posner G. Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy. Platelets. 2002;13(3):183–185. doi:10.1080/0953371027984
   PubMed Web of Science ®Google Scholar
• Zhou J, Jaquet A, Bissagnene E, et al. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc. 2012;15(1):1–12. doi:10.1186/1758-2652-15-5
   PubMedGoogle Scholar
• Nordic Medical Research Councils’ HIV Therapy Group. Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. BMJ. 1992;304:13–17. doi:10.1136/bmj.304.6818.13
   PubMedGoogle Scholar
• Berhane Y, Haile D, Tolessa T. Anemia in HIV/AIDS Patients on antiretroviral treatment at ayder specialized Hospital, Mekele, Ethiopia: a case-control study. J Blood Med. 2020;Volume 11:379–387. doi:10.2147/JBM.S275467
   Web of Science ®Google Scholar
• Phe T, Thai S, Veng C, Sok S, Lynen L, van Griensven J. Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment. PLoS One. 2013;8(3):e60206. doi:10.1371/journal.pone.0060206
   PubMed Web of Science ®Google Scholar
• Aynalem YA, Shibabaw Shiferaw W, Woldiye Z. Prevalence of anemia and its associated factors in antiretroviral-treated HIV/AIDS-positive adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia. Adv Hematol. 2020;2020:1–7. doi:10.1155/2020/2513578
   Google Scholar